Clinical trials recruiting in Tampico, Mexico

Phase breakdown

Conditions recruiting in Tampico, Mexico

Recruiting trials in Tampico, Mexico

• A Study of Dulaglutide (LY2189265) 3.0 mg and 4.5 mg in Pediatric Participants With Type 2 Diabetes Mellitus (AWARD-PEDS PLUS)
  NCT06739122 · Phase: Phase 3 · Ages: 10 Years to 17 Years · Sex: All (male and female)
• Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
  NCT07037433 · Phase: Phase 3 · Ages: 45 Years to 99 Years · Sex: All (male and female)
• Study of Efficacy and Safety of LNP023 in Participants With Active Lupus Nephritis Class III-IV, +/- V
  NCT05268289 · Phase: Phase 2 · Ages: 18 Years to 100 Years · Sex: All (male and female)

Common questions

How many clinical trials are recruiting in Tampico, Mexico?

3 recruiting trials have at least one study site in Tampico, Mexico.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.